HMGA2 and hepatocellular carcinoma: The inhibitor of HMGA2-sh-3p20 failed to downregulate the expression of HMGA2 at the levels of mRNA and protein (Supplementary Fig. S3C), implying that the levels of HMGA2-sh-3p20 are lower in hepatoma cells.